Autoinjector Compatibility
Autoinjector Compatibility is a sterile dosage form design criterion that denotes the physicochemical and functional suitability of a parenteral drug formulation to maintain stability, sterility, and delivery performance when administered via an autoinjector device.
5
Publications
85
Citations
29
Authors
10
Institutions
Publications per year
2017–2026
2
Parents
5
Ousama Rachid, F. Estelle R. Simons, Mutasem Rawas-Qalaji et al. · The Journal of Allergy and Clinical Immunology In Practice · 2015 · 21 citations
User trial of Easypod™, an electronic autoinjector for growth hormone
M. Tauber, Catherine Payen, Audrey Cartault et al. · Annales d Endocrinologie · 2008 · 18 citations
1–5 of 5
29
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 29
10
Hôpital des Enfants
Toulouse, France
1 h-index
5 publications
90 citations

University of Manitoba
Winnipeg, Canada
1 h-index
4 publications
84 citations
Centrum Medyczne iMed24
Krakow, Poland
1 h-index
2 publications
32 citations
Nova Southeastern University
Fort Lauderdale, United States
1 h-index
1 publications
21 citations
West Pharmaceutical Services (United States)
Exton, United States
1 h-index
2 publications
26 citations
Eli Lilly (United States)
Indianapolis, United States
1 h-index
7 publications
91 citations
Ludwig-Maximilians-Universität München
Munich, Germany
1 h-index
5 publications
85 citations
Merck Serono S.A.S. (France)
Lyon, France
1 h-index
1 publications
18 citations
1–8 of 10
1 publications · 13 citations
1
h-index
1 publications · 21 citations
1
h-index
1 publications · 16 citations
1
h-index
1 publications · 17 citations
1
h-index
1 publications · 18 citations
1
h-index
1–5